Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis

Meng, Ziqi; Wu, Jiarui; Liu, Xinkui; Zhou, Wei; Ni, Mengwei; Guo, Siyu; Jia, Shanshan; Zhang, Jingyuan

doi:10.1177/0300060520910019

Cited by 21 publications

(28 citation statements)

References 105 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The potential impact of these 5 hub ARGs on the progression of HCC were established. For example, TOP2A was identified as a potential biomarker for cancer therapy in ovarian cancer, colon cancer, pancreatic adenocarcinoma, and HCC [ 9 , 22 , 28 , 29 ]. However, TOP2A was upregulated in HCC [ 30 ].…”

Section: Discussionmentioning

confidence: 99%

“…Bioinformatics analysis is important in elucidating the functions of numerous differentially expressed genes as well as evaluating the complexity of HCC occurrence and development [ 7 , 8 ]. Meng et al used a series of bioinformatics analyses to identify hub genes and pathways associated with HCC pathogenesis and prognosis [ 9 ]. However, these studies usually ignore clinical information such as sex, age, grade, and stage of tumors.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A prognostic model for hepatocellular carcinoma based on apoptosis-related genes

et al. 2021

View full text Add to dashboard Cite

Background Dysregulation of the balance between proliferation and apoptosis is the basis for human hepatocarcinogenesis. In many malignant tumors, such as hepatocellular carcinoma (HCC), there is a correlation between apoptotic dysregulation and poor prognosis. However, the prognostic values of apoptosis-related genes (ARGs) in HCC have not been elucidated. Methods To screen for differentially expressed ARGs, the expression levels of 161 ARGs from The Cancer Genome Atlas (TCGA) database (https://cancergenome.nih.gov/) were analyzed. Gene Ontology (GO) enrichment and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to evaluate the underlying molecular mechanisms of differentially expressed ARGs in HCC. The prognostic values of ARGs were established using Cox regression, and subsequently, a prognostic risk model for scoring patients was developed. Kaplan–Meier (K-M) and receiver operating characteristic (ROC) curves were plotted to determine the prognostic value of the model. Results Compared with normal tissues, 43 highly upregulated and 8 downregulated ARGs in HCC tissues were screened. GO analysis results revealed that these 51 genes are indeed related to the apoptosis function. KEGG analysis revealed that these 51 genes were correlated with MAPK, P53, TNF, and PI3K-AKT signaling pathways, while Cox regression revealed that 5 ARGs (PPP2R5B, SQSTM1, TOP2A, BMF, and LGALS3) were associated with prognosis and were, therefore, obtained to develop the prognostic model. Based on the median risk scores, patients were categorized into high-risk and low-risk groups. Patients in the low-risk groups exhibited significantly elevated 2-year or 5-year survival probabilities (p < 0.0001). The risk model had a better clinical potency than the other clinical characteristics, with the area under the ROC curve (AUC = 0.741). The prognosis of HCC patients was established from a plotted nomogram. Conclusion Based on the differential expression of ARGs, we established a novel risk model for predicting HCC prognosis. This model can also be used to inform the individualized treatment of HCC patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

A prognostic model for hepatocellular carcinoma based on apoptosis-related genes

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The potential impact of these 5 hub ARGs on the progression of HCC were established. For example, TOP2A was identi ed as a potential biomarker for cancer therapy in ovarian cancer, colon cancer, pancreatic adenocarcinoma, and HCC [9,22,28,29]. However, TOP2A was up-regulated in HCC [30].…”

Section: Discussionmentioning

confidence: 99%

A prognostic model for hepatocellular carcinoma based on apoptosis-related genes

Liu

Wang

Zhang

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: Dysregulation of the balance between proliferation and apoptosis is the basis for human hepatocarcinogenesis. In many malignant tumors, such as hepatocellular carcinoma (HCC), there is a correlation between apoptotic dysregulation and poor prognosis. However, the prognostic values of apoptosis-related genes (ARGs) in HCC have not been elucidated. Methods: To screen for differentially expressed ARGs, the expression levels of 161 ARGs from The Cancer Genome Atlas (TCGA) database(https://cancergenome.nih.gov/) were analyzed. Gene Ontology (GO) enrichment and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to evaluate the underlying molecular mechanisms of differentially expressed ARGs in HCC. The prognostic values of ARGs were established using Cox regression, and subsequently, a prognostic risk model for scoring patients was developed. Kaplan-Meier (K-M) and receiver operating characteristic (ROC) curves were plotted to determine the prognostic value of the model. Results: Compared to normal tissues, 43 highly up-regulated and 8 down-regulated ARGs in HCC tissues were screened. GO analysis results revealed that these 51 genes are indeed related to the apoptosis function. KEGG analysis revealed that these 51 genes were correlated with MAPK, P53, TNF, and PI3K-AKT signaling pathways, while Cox regression revealed that 5 ARGs (PPP2R5B, SQSTM1, TOP2A, BMF, and LGALS3) were associated with prognosis and were, therefore, obtained to develop the prognostic model. Based on the median risk scores, patients were categorized into high-risk and low-risk groups. Patients in the low-risk groups exhibited significantly elevated two-year or five-year survival probabilities (p < 0.0001). The risk model had a better clinical potency than the other clinical characteristics, with the area under the ROC curve (AUC = 0.741). The prognosis of HCC patients was established from a plotted nomogram. Conclusion: Based on the differential expression of ARGs, we established a novel risk model for predicting HCC prognosis. This model can also be used to inform the individualized treatment of HCC patients.

show abstract

“…The potential impact of these ve hub ARGs on the progression of HCC were earlier observed. For example, Topoisomerase II alpha (TOP2A), was identi ed as a potential biomarker for cancer therapy in ovarian cancer, colon cancer, pancreatic adenocarcinoma and HCC [9,19,22,23]. However, TOP2A was up-regulated in HCC [24].…”

Section: Discussionmentioning

confidence: 99%

“…Bioinformatics analysis had been extensively adopted over the past few years as an effective tool in exploring functions of numerous differentially expressed genes (DEGs) and determining the complexity of HCC occurrence and development [7,8]. Hub genes and pathways associated with pathogenesis and prognosis of HCC via a series of bioinformatics analyses were established by Meng et al [9]. However, these studies usually ignore clinical information such as sex, age, grade, and stage of tumors.…”

Section: Introductionmentioning

confidence: 99%

Identification of hepatocellular carcinoma risk using a novel prognostic model based on apoptosis-related genes

Liu

Wang

Zhang

et al. 2021

Preprint

View full text Add to dashboard Cite

Background Dysregulation of the balance between proliferation and apoptosis is the basis in human hepatocarcinogenesis. There is a possible association of apoptosis dysregulation with poor prognosis in many malignant tumors, such as hepatocellular carcinoma (HCC). However, the prognostic effect of Apoptosis-related genes (ARGs) on HCC is still unclear. Methods A total of 161 ARGs expression levels were analyzed based on The Cancer Genome Atlas (TCGA) database(https://cancergenome.nih.gov/) to screen for differentially expressed ARGs. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to determine the underlying molecular mechanisms of screened ARGs in HCC. ARGs prognostic values were identified using Cox regression to subsequently establish a prognostic risk model and scoring in patients. Kaplan-Meier (K-M) and receiver operating characteristic (ROC) curves were plotted to determine the prognostic value in the model. Results Compared to normal specimens, 43 highly upregulated and 8 downregulated ARGs respectively and their normal counterparts in HCC specimens were screened. KEGG analysis demonstrated pathways correlated with these 51 genes which included MAPK, P53, TNF, PI3K-Akt signaling pathways. With Cox regression, 5 prognostic correlated with ARGs (PPP2R5B, SQSTM1, TOP2A, BMF, and LGALS3) were obtained to develop the prognosis model. According to the median of risk scores, patients were categorized into high-risk and low-risk groups. Patients in low-risk groups had a significantly higher two-year or five-year survival probability (p < 0.0001). The risk model had better potency than other clinical characteristics, with the area under the ROC curve (AUC = 0.741). Prognosis of HCC patients was established from a plotted nomogram. Conclusion This present study established a novel prognostic risk model for predicting HCC according to the expression of ARGs. The present advancement can potentially contribute to prediction prognosis and individualized treatment of HCC patients.

show abstract

Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis

Cited by 21 publications

References 105 publications

A prognostic model for hepatocellular carcinoma based on apoptosis-related genes

A prognostic model for hepatocellular carcinoma based on apoptosis-related genes

A prognostic model for hepatocellular carcinoma based on apoptosis-related genes

Identification of hepatocellular carcinoma risk using a novel prognostic model based on apoptosis-related genes

Contact Info

Product

Resources

About